e-learning
resources
Virtual 2021
07.09.2021
Asthma inhalers: new devices and adherence
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Use of short-acting ß2-agonists in patients with adult-onset asthma during 12-years
I. Vähätalo (Seinäjoki and Tampere, Finland), H. Kankaanranta (Seinäjoki, Tampere and Gothenburg, Finland), L. Tuomisto (Seinäjoki and Tampere, Finland), O. Niemelä (Seinäjoki and Tampere, Finland), L. Lehtimäki (Tampere, Finland), P. Ilmarinen (Seinäjoki and Tampere, Finland)
Source:
Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Session:
Asthma inhalers: new devices and adherence
Session type:
E-poster
Number:
3395
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Vähätalo (Seinäjoki and Tampere, Finland), H. Kankaanranta (Seinäjoki, Tampere and Gothenburg, Finland), L. Tuomisto (Seinäjoki and Tampere, Finland), O. Niemelä (Seinäjoki and Tampere, Finland), L. Lehtimäki (Tampere, Finland), P. Ilmarinen (Seinäjoki and Tampere, Finland). Use of short-acting ß2-agonists in patients with adult-onset asthma during 12-years. 3395
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Oral corticosteroid use in Swedish and Finnish severe asthma patients
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
12-year adherence to inhaled corticosteroids in adult-onset asthma
Source: ERJ Open Res, 6 (1) 00324-2019; 10.1183/23120541.00324-2019
Year: 2020
12-year adherence to inhaled corticosteroids in adult-onset asthma
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Re-evaluation of asthma diagnosis in patients with adult-onset asthma
Source: International Congress 2017 – New research in asthma and COPD
Year: 2017
Variability in asthma severity among steroid-naive patients previously receiving short-acting beta
2
-agonists
Source: Eur Respir J 2003; 22: Suppl. 45, 410s
Year: 2003
Use of bisoprolol: comparison of symptoms worsening in patients with asthma and COPD
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008
Use of long acting bronchodilators and inhaled corticosteroids within 30-days of discharge in older adults hospitalized for AECOPD
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Inhaled medication use in asthma and COPD Roma/Gypsies patients
Source: Eur Respir J 2005; 26: Suppl. 49, 610s
Year: 2005
Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018
Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Use of inhaled corticosteroids and the risk of depressive symptoms in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021
Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids
Source: Eur Respir J 2016; 48: 558-560
Year: 2016
Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes
Source: International Congress 2014 – Markers
Year: 2014
Prevalence of oral corticosteroid use in the German severe asthma population
Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019
Year: 2019
Use of parenteral long-term bronchodilators in the management of severe and life-threatening asthma
Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Year: 2003
Add-on effects of long-acting beta
2
-agonists salmeterol inhaler
vs
tulobuterol patch in adult patients with mild-to-moderate asthma
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept